445 related articles for article (PubMed ID: 31793228)
21. Four transcription profile-based models identify novel prognostic signatures in oesophageal cancer.
Liu T; Fang P; Han C; Ma Z; Xu W; Xia W; Hu J; Xu Y; Xu L; Yin R; Wang S; Zhang Q
J Cell Mol Med; 2020 Jan; 24(1):711-721. PubMed ID: 31746108
[TBL] [Abstract][Full Text] [Related]
22. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B.
Su JF; Zhao F; Gao ZW; Hou YJ; Li YY; Duan LJ; Lun SM; Yang HJ; Li JK; Dai NT; Shen FF; Zhou FY
Pathol Res Pract; 2020 Apr; 216(4):152848. PubMed ID: 32051106
[TBL] [Abstract][Full Text] [Related]
23. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.
Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM
Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501
[TBL] [Abstract][Full Text] [Related]
24. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma.
Xie K; Zheng C; Gu W; Jiang Z; Luo C; Luo J; Diao Y; Wang G; Cong Z; Yao X; Hu L; Shen Y
Thorac Cancer; 2022 Dec; 13(23):3341-3352. PubMed ID: 36266257
[TBL] [Abstract][Full Text] [Related]
25. A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Wang C
J Cell Physiol; 2019 May; 234(5):6810-6819. PubMed ID: 30387125
[TBL] [Abstract][Full Text] [Related]
26. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction.
Shang L; Hao JJ; Zhao XK; He JZ; Shi ZZ; Liu HJ; Wu LF; Jiang YY; Shi F; Yang H; Zhang Y; Liu YZ; Zhang TT; Xu X; Cai Y; Jia XM; Li M; Zhan QM; Li EM; Wang LD; Wei WQ; Wang MR
Oncotarget; 2016 Apr; 7(17):24374-82. PubMed ID: 27016410
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
28. LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.
Konishi T; Shiozaki A; Kosuga T; Kudou M; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
Am J Pathol; 2019 Oct; 189(10):1973-1985. PubMed ID: 31323188
[TBL] [Abstract][Full Text] [Related]
29. Expression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus.
Liu B; Li X; Liu F; Li F; Wei S; Liu J; Lv Y
Pathol Oncol Res; 2019 Oct; 25(4):1645-1652. PubMed ID: 30484263
[TBL] [Abstract][Full Text] [Related]
30. TGFBR3 is an independent unfavourable prognostic marker in oesophageal squamous cell cancer and is positively correlated with Ki-67.
Zhang X; Chen Y; Li Z; Han X; Liang Y
Int J Exp Pathol; 2020 Dec; 101(6):223-229. PubMed ID: 33146446
[TBL] [Abstract][Full Text] [Related]
31. Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.
Wang Y; Song T; Li K; Liu H; Han Y; Xu T; Cao F; Li Y; Yu Y
World J Surg Oncol; 2022 Jul; 20(1):236. PubMed ID: 35840985
[TBL] [Abstract][Full Text] [Related]
32. A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
Peng L; Guo JC; Long L; Pan F; Zhao JM; Xu LY; Li EM
Biomed Res Int; 2019; 2019():3869825. PubMed ID: 31815134
[TBL] [Abstract][Full Text] [Related]
33. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
[TBL] [Abstract][Full Text] [Related]
34. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population.
Rong L; Wang B; Guo L; Liu X; Wang B; Ying J; Xue L; Lu N
Diagn Pathol; 2020 Mar; 15(1):27. PubMed ID: 32209107
[TBL] [Abstract][Full Text] [Related]
35. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
36. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
[TBL] [Abstract][Full Text] [Related]
37. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
[TBL] [Abstract][Full Text] [Related]
38. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
39. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
[TBL] [Abstract][Full Text] [Related]
40. Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study.
Li K; Lin Y; Zhou Y; Xiong X; Wang L; Li J; Zhou F; Guo Y; Chen S; Chen Y; Tang H; Qiu X; Cai S; Zhang D; Bremer E; Jim Yeung SC; Zhang H
Gastroenterology; 2023 Oct; 165(4):932-945.e9. PubMed ID: 37399999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]